Literature DB >> 33576897

Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis.

Zhendong Liu1, Fangmi Ding1, Xingyong Shen2.   

Abstract

This study aimed to investigate the effects of the total flavonoids of Radix Tetrastigma (RTF) on inflammation-related hepatocellular carcinoma (HCC) development. Extracted RTF was diluted to different concentrations for subsequent experiments. HCC cells were cotreated with lipopolysaccharide (LPS) and RTF to investigate the effects of RTF on LPS-stimulated HCC cells. A CCK-8 kit was used to measure cell proliferation. Apoptosis was detected with a flow cytometer. Cell migration and invasion were quantified by wound healing and Transwell assays, respectively. The expression of TLR4 and COX-2 and activation of the NF-κB pathway were determined by Western blotting. Treatment with LPS significantly enhanced cell proliferation and decreased the apoptosis rate, while cell migration and invasion were notably upregulated. RTF suppressed the proliferation and invasion induced by LPS stimulation and promoted HCC cell apoptosis. The protein levels of Bax and cleaved caspase-3 were decreased and that of Bcl-2 was increased by LPS in HCC cells, which could be rescued by RTF. RTF significantly inhibited the LPS-induced expression of the proinflammatory mediators IL-6 and IL-8 in HCC cells. Mechanistically, with RTF treatment, the upregulated expression of TLR4 and COX-2 induced by LPS was obviously downregulated. Furthermore, the phosphorylation of NF-κB/p65 was significantly decreased in LPS-stimulated cells after supplementation with RTF. Our study suggests that RTF exerts a significant inhibitory effect on the LPS-induced enhancement of the malignant behaviors of HCC cells via inactivation of TLR4/NF-κB signaling. RTF may be a promising chemotherapeutic agent to limit HCC development and inflammation-mediated metastasis.

Entities:  

Keywords:  Hepatocellular carcinoma; NF-κB/p65; Radix Tetrastigma; TLR4

Year:  2021        PMID: 33576897     DOI: 10.1007/s00438-020-01759-6

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  6 in total

1.  Isolation and identification of antiproliferative compounds from the roots of Tetrastigma hemsleyanum against MDA-MB-435S cell lines.

Authors:  Zhucan Lin; Liyun Chen; Qi Qiu; Suhua Guo
Journal:  Pak J Pharm Sci       Date:  2016-07       Impact factor: 0.684

2.  Curcumin inhibits liver cancer by inhibiting DAMP molecule HSP70 and TLR4 signaling.

Authors:  Biqiong Ren; Shudi Luo; Xuefei Tian; Zhichao Jiang; Guoying Zou; Fei Xu; Tieqiu Yin; Yiran Huang; Junlong Liu
Journal:  Oncol Rep       Date:  2018-06-11       Impact factor: 3.906

3.  Antitumor activity of total flavonoids from Tetrastigma hemsleyanum Diels et Gilg is associated with the inhibition of regulatory T cells in mice.

Authors:  Zhengquan Feng; Wanrong Hao; Xiaoyang Lin; Daping Fan; Juhua Zhou
Journal:  Onco Targets Ther       Date:  2014-06-09       Impact factor: 4.147

4.  TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.

Authors:  Kunlin Wu; Huihao Zhang; Yajuan Fu; Youzhi Zhu; Lingjun Kong; Ling Chen; Feng Zhao; Liangfei Yu; Xiangjin Chen
Journal:  Mol Med Rep       Date:  2018-07-26       Impact factor: 2.952

5.  The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer.

Authors:  Junsheng Gu; Ranran Sun; Shen Shen; Zujiang Yu
Journal:  Onco Targets Ther       Date:  2015-08-21       Impact factor: 4.147

Review 6.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics.

Authors:  Renumathy Dhanasekaran; Alpna Limaye; Roniel Cabrera
Journal:  Hepat Med       Date:  2012-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.